Jian Guo Ren

Jian-Guo received his Ph.D. in Molecular, Cellular and Developmental Biology from Tsinghua University, Beijing. He completed his postdoctoral training at the Johns Hopkins University School of Medicine and Harvard Medical School and served afterwards as a Senior Research Faculty member at Harvard Medical School and Beth Israel Deaconess Hospital.

His experience spans multiple areas, including tumor metabolism, novel targets discovery for cancer therapy, biomarker screening for clinical efficacy evaluation, small molecule and antibody-based PROTACs to target intracellular undruggable targets and assay platform development for different modalities such as ASO library construction for exon skipping, stapled-peptides library screening undruggable targets, as well as rare diseases in vitro and in vivo model selection and development. He has special interest in cancer immunotherapy and tumor relapse.

At Dewpoint, he has great interest in discovering novel immunotherapy drugs using condensate biology platform to develop novel treatments for tumor patients.